Given the following passage "Since there were few posts in Hungary for mathematicians, and those were not well-paid, his father wanted von Neumann to follow him into industry and therefore invest his time in a more financially useful endeavor than mathematics. So it was decided that the best career path was to become a chemical engineer. This was not something that von Neumann had much knowledge of, so it was arranged for him to take a two-year non-degree course in chemistry at the University of Berlin, after which he sat the entrance exam to the prestigious ETH Zurich, which he passed in September 1923. At the same time, von Neumann also entered Pazmany Peter University in Budapest, as a Ph.D. candidate in mathematics. For his thesis, he chose to produce an axiomatization of Cantor's set theory. He passed his final examinations for his Ph.D. soon after graduating from ETH Zurich in 1926. He then went to the University of Gottingen on a grant from the Rockefeller Foundation to study mathematics under David Hilbert.", answer the following question. Note that the answer is present within the text. Question: What was the issue with the decision?
----
Answer: This was not something that von Neumann had much knowledge of

Given the following passage "During encoding, 576 time-domain samples are taken and are transformed to 576 frequency-domain samples.[clarification needed] If there is a transient, 192 samples are taken instead of 576. This is done to limit the temporal spread of quantization noise accompanying the transient. (See psychoacoustics.)", answer the following question. Note that the answer is present within the text. Question: When are 192 samples taken?
----
Answer: If there is a transient

Given the following passage "In the United States, new pharmaceutical products must be approved by the Food and Drug Administration (FDA) as being both safe and effective. This process generally involves submission of an Investigational New Drug filing with sufficient pre-clinical data to support proceeding with human trials. Following IND approval, three phases of progressively larger human clinical trials may be conducted. Phase I generally studies toxicity using healthy volunteers. Phase II can include pharmacokinetics and dosing in patients, and Phase III is a very large study of efficacy in the intended patient population. Following the successful completion of phase III testing, a New Drug Application is submitted to the FDA. The FDA review the data and if the product is seen as having a positive benefit-risk assessment, approval to market the product in the US is granted.", answer the following question. Note that the answer is present within the text. Question: What does the FDA oversee?
----
Answer:
new pharmaceutical products